Apsen Pharmaceuticals
- Company typePrivate
- Founded1969
- HeadquartersSão Paulo, Brazil
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Apsen Pharmaceuticals firmographics
Firmographics- Name
- Apsen Pharmaceuticals
- Legal name
- Apsen Farmacêutica S.A.
- Website
- https://apsen.com.br
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Apsen Pharmaceuticals industry classification
Industry- Product category
- Branded Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
Keywords
Where Apsen Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Apsen Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- Prescription Medications: Core revenue from branded prescription pharmaceuticals across therapeutic areas including Neurology, Psychiatry, Otolaryngology, Urology, Gynecology, Rheumatology, Orthopedics, Gastroenterology, Geriatrics, Endocrinology, Angiology. Portfolio of 50+ medications with 14 exclusive products.
- Nutritional Supplements: Functional food supplements including probiotics (Lactosil Flora, Probid), psychobiotics (Probians), and vitamins. Products sold through pharmacies targeting gastrointestinal health, mental health via gut-brain axis, and lactose intolerance.
- Over-the-Counter (MIPs): Medications exempt from prescription (Medicamentos Isentos de Prescrição) as part of growing OTC portfolio alongside supplements.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
Apsen Pharmaceuticals product offering
Product offeringCore offering
Apsen manufactures and distributes a portfolio of 50+ branded prescription medications across therapeutic areas including Neurology, Psychiatry, Otolaryngology, Urology, Gynecology, Rheumatology, Orthopedics, Gastroenterology, Geriatrics, Endocrinology, and Angiology. The company also produces functional nutritional supplements including probiotics, psychobiotics, and vitamins. Products are sold through pharmacy chains and pharmaceutical distributors in Brazil, supported by a direct field sales force engaging physicians.
Product overview
Apsen Pharmaceuticals is a Brazilian pharmaceutical company with a diversified portfolio of 54+ products including prescription medications, supplements, and digital health platforms. The medication portfolio covers multiple therapeutic areas: Central Nervous System (Alois, Donaren, Inseris XR, Luratt), Musculoskeletal (Miosan, Flancox, Insit), Gastroenterology (Inilok, Lonium, Probid), Urology (Uro-vaxom, Retemic, Unoprost), Vascular (Dobeven, Zanidip), and Anti-infectives (Levoxin, Traturil). The supplement line includes functional products like Lactosil Flora (lactase + probiotic), Probid (probiotic with functional claim), and Probians (psychobiotic for gut-brain axis). Digital offerings include Sou Mais Vida patient program, Sala VIP Apsen for healthcare professionals, and health information portals like TDAH Levado a Sério. The company also operates internal digital platforms including the Nação Azul employee app and ApsenCast podcast. Major awards include PROFA DE OURO 2023 RX Champion, LUPA DE OURO awards for CNS and musculoskeletal products, and Innovation Leader Award 2023.
Differentiator
Problem solved
Functional benefit
Brands
- Sou Mais Vida: Customer relationship program providing access to prescribed products with exclusive benefits
- Sala VIP Apsen
- Nação Azul
- Lactosil Flora
- Probid
- Probians
Products and services
- Alois (Alois Comprimido, Alois Duo, Alois Gotas) Neurology prescription medication family for Alzheimer's disease treatment, containing memantine hydrochloride (Alois Comprimido, Alois Gotas) and donepezil + memantine combination (Alois Duo). Sold through pharmacies with medical prescription for treating neurological conditions in geriatric patients.
- Donaren / Donaren Retard / Inseris XR
Quantifiable outcome
- 70% of previously manual processes automated through ServiceNow implementation
- +7 more outcomes
Companies that use Apsen Pharmaceuticals
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Apsen Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Apsen Pharmaceuticals partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, flagship and minor.
- Rimini StreetcorePartnership with Rimini Street to implement ServiceNow workflow automation over existing SAP ECC 6 ERP, avoiding costly migration to SAP S/4HANA. Enables enterprise-wide process automation, achieving 70% automation of previously manual processes.
- ServiceNowcoreServiceNow platform implementation enabling enterprise workflow automation across Apsen operations, reducing process development cycles from months to weeks. Partnership announced at ServiceNow's Knowledge 2025 event.
- Hospital Israelita Albert EinsteinflagshipHistoric partnership establishing the first Einstein Clinic in a national pharmaceutical industry at Apsen's headquarters. Provides excellence healthcare including Family Doctor, Family Nurse, Care Coordination team, Einstein Telemedicine, and Mental Health Program for all Apsen employees nationwide.
- SBU - Sociedade Brasileira de UrologiacorePartnership with Brazilian Urology Society (São Paulo and Rio de Janeiro sections) for FelizIdade campaign, raising awareness about Benign Prostatic Hyperplasia (BPH), providing free examinations and health information to Brazilian men.
- Abrafarma - Associação Brasileira de Redes de Farmácias e DrogariascorePartnership with Brazilian Pharmacy Chains Association for healthcare awareness campaigns including FelizIdade campaign for prostate health, combining pharmacy reach with medical expertise.
- Coop - Cooperativa de ConsumominorSocial partnership providing free gynecological care in five locations in São Paulo as part of International Women's Day celebrations and women's health awareness initiatives.
- Lallemand (Canada)corePartnership with Canadian laboratory Lallemand to produce Probians, Brazil's first psychobiotic supplement. Lallemand provides probiotic strains (Lactobacillus helveticus R0052 ND and Bifidobacterium longum R0175) with proven gut-brain axis efficacy.
- ProfarmacoreDistribution partnership with Profarma, the 2nd largest pharmaceutical distributor in Brazil. Recognition as PROFA DE OURO 2023 champion in RX category and TopFornecedor 2023 demonstrates strong commercial relationship.
Scale indicators10 records
Recent moves8 records
Expansion highlights5 records
Apsen Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Eurofarma Laboratórios: One of Brazil's largest 100% national pharmaceutical companies, with a diversified branded generics and specialty pharma portfolio across CNS, women's health, and prescription medications. Directly comparable to Apsen in scale, Brazilian-only focus, family-influenced governance, and field-sales-driven GTM targeting physicians.
- EMS Pharma: Largest Brazilian pharmaceutical company by volume, with leadership in branded generics and a growing specialty and biosimilar franchise. Competes head-to-head with Apsen in CNS, urology, and gastroenterology categories and shares the same pharmacy-chain and distributor go-to-market.
- Mantecorp Farmasa: Brazilian pharmaceutical company with a portfolio spanning prescription and OTC products, including CNS, dermatology, and women's health. Comparable mid-tier Brazilian specialty pharma competing for similar physician mindshare and pharmacy shelf space.
- Aché Laboratórios Farmacêuticos: Major Brazilian pharmaceutical company with broad prescription and OTC portfolio spanning CNS, dermatology, respiratory, and musculoskeletal categories. Comparable in size, domestic focus, and therapeutic-area overlap with Apsen, and serves similar physician and pharmacy distribution channels.
- Biolab Farmacêutica: Brazilian pharmaceutical company focused on prescription specialties including cardiology, gynecology, dermatology, and CNS. Comparable as a mid-tier Brazilian specialty pharma with similar therapeutic-area mix and reliance on physician detailing.
- Cristália Produtos Químicos Farmacêuticos: Brazilian pharmaceutical company combining specialty pharma, hospital products, and APIs/manufacturing. Comparable to Apsen in domestic manufacturing focus and CNS portfolio, with additional hospital and institutional exposure.
- Hypera Pharma (Hyperabras / DM): Brazil's largest pharma company by revenue, formed through the consolidation of Hypermarcas and DM. Operates across prescription, OTC, and consumer health categories with a strong branded portfolio. Public-market listed (B3: HYPE3), providing a direct valuation benchmark for a scaled Brazilian specialty pharma peer.
- Libbs Farmacêutica: 100% Brazilian pharmaceutical company with a strong presence in women's health, CNS, dermatology, and specialty categories. Operates a similar prescription-pharma model with field sales force and pharmacy distribution, competing in overlapping therapeutic areas.
Broad incumbents
- Sanofi (Brazil operations): Global pharmaceutical company with a significant Brazil commercial presence spanning vaccines, specialty care, and primary care. Overlaps with Apsen in CNS, urology, and cardiovascular categories but at vastly larger scale and with global R&D; competes for the same specialist physicians in Brazil.
- Pfizer (Brazil operations): Global pharmaceutical incumbent with a major Brazil commercial footprint across primary care, specialty, and vaccines. Competes with Apsen in CNS and urology categories (e.g., pregabalin, OAB) and represents the multinational benchmark for therapeutic-area scale and R&D capacity in Brazil.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Apsen Pharmaceuticals social profiles
Digital presenceApsen Pharmaceuticals compliance and trust
Trust signalCompliance6 records
Apsen Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Apsen Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles8 records
Apsen Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Apsen Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Apsen Pharmaceuticals
What does Apsen Pharmaceuticals do?
Apsen manufactures and distributes a portfolio of 50+ branded prescription medications across therapeutic areas including Neurology, Psychiatry, Otolaryngology, Urology, Gynecology, Rheumatology, Orthopedics, Gastroenterology, Geriatrics, Endocrinology, and Angiology. The company also produces functional nutritional supplements including probiotics, psychobiotics, and vitamins. Products are sold through pharmacy chains and pharmaceutical distributors in Brazil, supported by a direct field sales force engaging physicians.
Is Apsen Pharmaceuticals a public or private company?
Apsen Pharmaceuticals is a private company. It is classified as family owned and is currently operating.
When was Apsen Pharmaceuticals founded?
Apsen Pharmaceuticals was founded in 1969. It employs 501 to 1,000 people.
Where is Apsen Pharmaceuticals based?
Apsen Pharmaceuticals is headquartered in São Paulo, Brazil, in the Latin America region.
How does Apsen Pharmaceuticals make money?
Three revenue lines are on record. Prescription Medications are the primary driver. The others are nutritional Supplements and over-the-Counter (MIPs).
Who are Apsen Pharmaceuticals's main competitors?
Direct peers on record are Eurofarma Laboratórios, EMS Pharma, Mantecorp Farmasa, Aché Laboratórios Farmacêuticos, Biolab Farmacêutica, Cristália Produtos Químicos Farmacêuticos, Hypera Pharma (Hyperabras / DM) and Libbs Farmacêutica. Broad incumbents are Sanofi (Brazil operations) and Pfizer (Brazil operations).
Does Apsen Pharmaceuticals have an API?
No public API is recorded for Apsen Pharmaceuticals.
What industry is Apsen Pharmaceuticals in?
Apsen Pharmaceuticals's product category is Branded Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.